Moving at paceWow, what a huge acquisition. Oncidium is growing at 30% "without" forward cross-sell opportunities.....amazing!
A couple of days ago I said I saw DOC hitting at least $150MM run rate in 2021 and around $8/share........
Today we are around 25% of the valuation of WELL at half their projected revenue....and DOC states it will deliver profitability this year..
Tick Tick Tick....!